MedPath

Lidocaine

Generic Name
Lidocaine
Brand Names
Agoneaze, Akten, Alivio, Anestacon, Anodyne Lpt, Astero, Band-aid Hurt-free, Cathejell, Curacaine, Depo-medrol With Lidocaine, Dermacinrx Lido V Pak, Dermacinrx Phn Pak, Dermacinrx Prikaan, Diphen, Emla, Fortacin, Glydo, Instillagel, Kenalog, Lido Bdk, Lido-prilo Caine Pack, Lidocan, Lidodan, Lidoderm, Lidopac, Lidopril, Lidopro, Lidosol, Lidothol, Lidotral, Lignospan, Marcaine, Max-freeze, Medi-derm With Lidocaine, Neo-bex, Octocaine, Octocaine With Epinephrine, Oraqix, P-care, P-care X, Pliaglis, Prilolid, Prizotral, Procomycin, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Relador, Synera, Triple Antibiotic, Venipuncture Px1, Viadur, Xylocaine, Xylocaine With Epinephrine, Xylocard, Xylonor, Zingo, Ztlido
Drug Type
Small Molecule
Chemical Formula
C14H22N2O
CAS Number
137-58-6
Unique Ingredient Identifier
98PI200987
Background

Ever since its discovery and availability for sale and use in the late 1940s, lidocaine has become an exceptionally commonly used medication . In particular, lidocaine's principal mode of action in acting as a local anesthetic that numbs the sensations of tissues means the agent is indicated for facilitating local anesthesia for a large variety of surgical procedures . It ultimately elicits its numbing activity by blocking sodium channels so that the neurons of local tissues that have the medication applied on are transiently incapable of signaling the brain regarding sensations . In doing so, however, it can block or decrease muscle contractile, resulting in effects like vasodilation, hypotension, and irregular heart rate, among others . As a result, lidocaine is also considered a class Ib anti-arrhythmic agent . Nevertheless, lidocaine's local anesthetic action sees its use in many medical situations or circumstances that may benefit from its action, including the treatment of premature ejaculation .

Regardless, lidocaine is currently available as a relatively non-expensive generic medication that is written for in millions of prescriptions internationally on a yearly basis. It is even included in the World Health Organization's List of Essential Medicines .

Indication

Lidocaine is an anesthetic of the amide group indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks .

Associated Conditions
Acute Otitis Media (AOM), Anorectal discomfort, Arrhythmia, Back Pain Lower Back, Bacterial Vaginosis (BV), Burns, Cervical Syndrome, Earache, Fissure;Anal, Haemorrhoids, Infection, Inflammatory Reaction caused by ear infection-not otherwise specified, Insect Bites, Joint Pain, Mixed Vaginal Infections, Multiple Myeloma (MM), Myringitis, Neuritis, Osteolysis caused by Bone Tumors, Osteoporosis, Otitis Externa, Pain caused by ear infection-not otherwise specified, Pain, Inflammatory, Postherpetic Neuralgia, Primary Hyperparathyroidism (PHPT), Rheumatic Diseases, Rheumatic Joint Disease, Sciatica, Skin Irritation, Soft Tissue Inflammation, Sore Throat, Sunburn, Susceptible infections, Trichomonas Vaginitis, Ulcers, Leg, Urethral Strictures, Ventricular Arrhythmia, Vulvovaginal Candidiasis, Abrasions, Anal discomfort, Cutaneous lesions, Gum pain, Minor burns, Superficial Wounds, Susceptible Bacterial Infections, Ulceration of the mouth, Viral infections of the external ear canal
Associated Therapies
Local Anaesthesia therapy, Post Myocardial Infarction Treatment, Regional Anesthesia therapy

Lidocaine For Neuroprotection During Cardiac Surgery

Not Applicable
Completed
Conditions
Cognitive Decline
Interventions
Drug: Placebo
Drug: Lidocaine
First Posted Date
2009-07-14
Last Posted Date
2019-05-10
Lead Sponsor
Duke University
Target Recruit Count
550
Registration Number
NCT00938964
Locations
🇺🇸

Sentara Cardiovascular Research Institute, Norfolk, Virginia, United States

🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Greater Occipital Nerve Block for Migraine Prophylaxis

Phase 4
Completed
Conditions
Migraine Headache
Interventions
Drug: bupivicaine
Drug: normal saline
Drug: methylprednisolone
Drug: lidocaine
First Posted Date
2009-06-08
Last Posted Date
2014-03-20
Lead Sponsor
Mayo Clinic
Target Recruit Count
70
Registration Number
NCT00915473
Locations
🇺🇸

Mayo Clinic, Phoenix, Arizona, United States

Analgesic Effect of Perioperative Systemic Lidocaine in Patients Undergoing Unilateral Mastectomy Surgery

Phase 4
Terminated
Conditions
Pain
Interventions
Drug: Placebo
Drug: Lidocaine
First Posted Date
2009-06-03
Last Posted Date
2015-02-04
Lead Sponsor
Northwestern University
Target Recruit Count
22
Registration Number
NCT00913003

Source of Hand Weakness After Stroke

Phase 2
Withdrawn
Conditions
Stroke
Cerebrovascular Accident
Interventions
Drug: lidocaine
Device: muscle stimulator
First Posted Date
2009-05-25
Last Posted Date
2014-05-05
Lead Sponsor
US Department of Veterans Affairs
Registration Number
NCT00907829
Locations
🇺🇸

Edward Hines, Jr. VA Hospital, Hines, Illinois, United States

Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee

Phase 4
Terminated
Conditions
Osteoarthritis of the Knee
Interventions
First Posted Date
2009-05-19
Last Posted Date
2010-02-15
Lead Sponsor
Endo Pharmaceuticals
Registration Number
NCT00904605

Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy

Phase 4
Completed
Conditions
Diabetes
Interventions
First Posted Date
2009-05-19
Last Posted Date
2010-02-15
Lead Sponsor
Endo Pharmaceuticals
Target Recruit Count
76
Registration Number
NCT00903851

Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee

Phase 2
Completed
Conditions
Osteoarthritis, Knee
Interventions
Drug: Placebo patch
Drug: Lidoderm
First Posted Date
2009-05-19
Last Posted Date
2010-02-10
Lead Sponsor
Endo Pharmaceuticals
Target Recruit Count
224
Registration Number
NCT00904462

A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Phase 4
Completed
Conditions
Postherpetic Neuralgia
Diabetic Neuropathy
Low Back Pain
Interventions
First Posted Date
2009-05-19
Last Posted Date
2024-01-02
Lead Sponsor
Endo Pharmaceuticals
Target Recruit Count
107
Registration Number
NCT00904020

Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia

Phase 4
Completed
Conditions
Pudendal Neuralgia
Canal Syndrome
Interventions
Drug: Lidocaine
Drug: Depmedrol
Other: physiological serum
First Posted Date
2009-02-26
Last Posted Date
2013-09-04
Lead Sponsor
Nantes University Hospital
Target Recruit Count
202
Registration Number
NCT00851513
Locations
🇫🇷

CH de la Côte Basque, Bayonne, France

🇫🇷

CHU de Nantes, Nantes, France

🇫🇷

Scanner Saint Hilaire, Rouen, France

and more 6 locations

Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery

Not Applicable
Completed
Conditions
Spine Surgery
Interventions
Drug: placebo
Drug: Lidocaine
First Posted Date
2009-02-11
Last Posted Date
2016-12-23
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
116
Registration Number
NCT00840996
Locations
🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath